Practice of Comparative Effectiveness Research to Identify Treatment Characteristics of Similar Chinese Patent Medicine for Angina Pectoris

被引：12

作者：

Cao, Hongbo ^{[1
,2
]}

Wang, Ping ^{[2
]}

Li, Nan ^{[1
]}

Liu, Dan ^{[3
]}

Ma, Junshao ^{[4
]}

Fan, Ruihong ^{[5
]}

Zhou, Zhihuan ^{[1
]}

机构：

[1] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China

[2] Ctr Evidence Based Med, Tianjin, Peoples R China

[3] Wuqing Hosp Tradit Chinese Med, Tianjin, Peoples R China

[4] Nakai Hosp, Tianjin, Peoples R China

[5] Hosp Tradit Chinese Med, Tianjin, Peoples R China

来源：

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | 2017年 / 2017卷

基金：

中国国家自然科学基金;

关键词：

DIFFERENTIATION;

D O I：

10.1155/2017/7062714

中图分类号：

R [医药、卫生];

学科分类号：

100218 [急诊医学];

摘要：

Objective. Individualized application of TCM is not easy and may lead to undesirable results, such as poor effect or even adverse reactions. This trial aims to compare two common Chinese patent medicines with similar effects. Background of the Research. Four hospitals carried out the test at the same time in Tianjin city of China. Participants. 144 patients were involved in this study; all patients must meet the diagnostic criteria. Interventions. Qishen Yiqi pills, compound danshen pills, and their placebos; an efficacy analysis was conducted after the first medication and after crossover medication. Primary Outcome Measures. The primary index of end point includes Seattle Angina Questionnaire score-7 and score of 7-point Likert Scale; the curative effect was compared with minimal clinically important differences value. Result. Two drugs have their respective advantages in treating SAP. In practical application, the two drugs shall be discriminated in use based on patients' specific symptoms.

引用

页数：9

共 24 条

[1]

[Anonymous], 2015, MEDICINE

[2]

Cao H., 2015, BMJ OPEN, V4

[3]

Cao Hong-bo, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P369

[4]

Chen Zhi-Qiang, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P1126

[5]